Showing results (251-260 of 321) with videos related to
Sort By:
Pageof 33
Behavioural Neurology|September 25, 2001
Storage of verbal associations is sufficient to activate the left medial temporal lobeAndrew R. Mayes, Patricia A. Gooding, Nicola M. Hunkin, et al.Personality Disorders|April 2, 2026
Does the severity of specific borderline personality disorder symptoms vary by sexual orientation? A differential item functioning analysis of self- and clinician-ratingsAlexandra K Barnhill, Julia K Nicholas, Hannah E Croom, et al.Pain|June 4, 2015
The Pain Course: a randomised controlled trial examining an internet-delivered pain management program when provided with different levels of clinician supportBlake F Dear, Milena Gandy, Eyal Karin, et al.AIDS Care|January 4, 2003
Self-care management for neuropathy in HIV diseaseP K Nicholas, J K Kemppainen, W L Holzemer, et al.Arthritis Care & Research|September 30, 2015
Physical Therapist-Delivered Pain Coping Skills Training and Exercise for Knee Osteoarthritis: Randomized Controlled TrialKim L Bennell, Yasmin Ahamed, Gwendolen Jull, et al.Journal of Medical Genetics|November 26, 2008
The molecular landscape of ASPM mutations in primary microcephalyA K Nicholas, E A Swanson, J J Cox, et al.Scandinavian Journal of Pain|April 4, 2020
Pain psychology in the 21st century: lessons learned and moving forwardIda K Flink, Silje Reme, Henrik Børsting Jacobsen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent GlioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.The Journal of Allergy and Clinical Immunology|August 15, 2016
Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiencyChiara Bacchelli, Federico A Moretti, Marlene Carmo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.Pageof 33